AIC
GNOM icon

Archer Investment Corporation’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Archer Investment Corporation’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-25
Closed -$2.25K – 603
2021
Q1 		$2.25K Buy
+25
New +$2.47K ﹤0.01% 670

Other funds holding GNOM

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Archer Investment Corporation's GNOM Position: Q2 2021 in Review

Archer Investment Corporation sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2021, closing a stake of 25 shares — an estimated $2.25K sold.

Archer Investment Corporation first reported a position in GNOM in Q1 2021 and held it in 1 quarter. The position peaked at $2.25K in Q1 2021. 46 funds tracked by Wall St. Rank hold GNOM as of Q2 2021.

  • Archer Investment Corporation reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
  • Archer Investment Corporation sold 25 Global X Genomics & Biotechnology ETF shares in Q2 2021, an estimated $2.25K.
  • Archer Investment Corporation first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 1 quarter.
  • Archer Investment Corporation's Global X Genomics & Biotechnology ETF position peaked at $2.25K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2021.

Based on Archer Investment Corporation's 13F filing for Q2 2021, filed 5 Aug 2021.